98%
921
2 minutes
20
In recent years, lung US has evolved from a marginal tool to an integral component of diagnostic chest imaging. Contrast-enhanced US (CEUS) can improve routine gray-scale imaging of the lung and chest, particularly in diagnosis of peripheral lung diseases (PLDs). Although an underused tool in many centers, and despite inherent limitations in evaluation of central lung disease caused by high acoustic impedance between air and soft tissues, lung CEUS has emerged as a valuable tool in diagnosis of PLDs. Owing to the dual arterial supply to the lungs via pulmonary and bronchial (systemic) arteries, different enhancement patterns can be observed at lung CEUS, thereby enabling accurate differential diagnoses in various PLDs. Lung CEUS also assists in identifying patients who may benefit from complementary diagnostic tests, including image-guided percutaneous biopsy. Moreover, lung CEUS-guided percutaneous biopsy has shown feasibility in accessible subpleural lesions, enabling higher histopathologic performance without significantly increasing either imaging time or expenses compared with conventional US. The authors discuss the technique of and basic normal and pathologic findings at conventional lung US, followed by a more detailed discussion of lung CEUS applications, emphasizing specific aspects of pulmonary physiology, basic concepts in lung US enhancement, and the most commonly encountered enhancement patterns of different PLDs. Finally, they discuss the benefits of lung CEUS in planning and guidance of US-guided lung biopsy. RSNA, 2024 Supplemental material is available for this article.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1148/rg.230171 | DOI Listing |
Front Surg
May 2025
Department of Thoracic Surgery and Lung Transplant, University Hospital Vall d´Hebron, Barcelona, Spain.
The aim of this study was to show the efficacy described in the scientific literature of lung ultrasound (LU) during video-assisted thoracic surgery (VATS) to determine the location and characterization of pulmonary nodules. The results showed that intraoperative LU is especially useful in localizing lung lesions by VATS with a sensitivity close to 100%. It was also shown to be useful in planning very precise lung resections, reducing the resection of healthy lung tissue.
View Article and Find Full Text PDFCancers (Basel)
May 2025
Diagnostic and Therapeutic Interventional Ultrasound Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
This systematic review describes a largely descriptive synthesis of studies investigating the diagnostic performance of quantitative contrast-enhanced ultrasound (CEUS) in differentiating benign from malignant peripheral pulmonary lesions. : Formal quantitative pooling of effect sizes was not feasible due to variability in outcome measurements and reporting. Combining CEUS parameters with real-time on-site evaluation (ROSE) substantially improved percutaneous biopsy success rates.
View Article and Find Full Text PDFFront Oncol
April 2025
Department of Ultrasound, Clinical Medical College and the First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
Objective: This study assesses the clinical utility of contrast - enhanced ultrasound (CEUS) in comparison to contrast - enhanced computed tomography (CECT) in the context of peripheral lung mass biopsy. The overarching objective is to establish robust clinical benchmarks that can guide evidence - based decision - making in the field of pulmonary interventional procedures.
Methods: A comparison of 420 patients admitted to our hospital from January 2019 to December 2022 who underwent biopsy using two different guidance methods, including 196 cases in the CEUS-guided biopsy group and 224 cases in the CECT-guided biopsy group.
BMC Med Imaging
May 2025
National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Ultrasound, Center of Respiratory Medicine, China
Background: This study compares the success rate, diagnostic accuracy, and safety of contrast-enhanced ultrasound (CEUS)-guided biopsy versus conventional ultrasound (US)-guided biopsy for thoracic and pulmonary lesions.
Methods: A systematic search of PubMed, EMBASE, Web of Science, and Cochrane Library was conducted. The primary outcomes included success rate and diagnostic accuracy, and the secondary outcome was the odds ratio of adverse effects.
J Clin Ultrasound
July 2025
Department of Ultrasound, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, China.
Purpose: Lung cancer is a leading cause of death; however, its diagnosis needs to be improved. This study aimed to compare the performances of the contrast agents Sonazoid and SonoVue in quantitative analysis in the contrast-enhanced ultrasound (CEUS) of peripheral lung cancer lesions (PLCLs).
Methods: This retrospective study included patients with PLCLs between January 2021 and January 2024.